Product
Rulonilimab+Lenvatinib
1 clinical trial
1 indication
Indication
Hepatocellular CarcinomaClinical trial
Phase Ⅱ/III Studies to Investigate the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib Compared to Placebo in Combination With Lenvatinib as First-Line Therapy in Subjects With Hepatocellular CarcinomaStatus: Recruiting, Estimated PCD: 2025-08-01